Agilent Technologies

D

الأسعار متأخرة 15 دقيقة

ملف شركة Agilent Technologies

الرئيس التنفيذي

Padraig McDonnell

عدد الموظفين

18,200

المقر الرئيسي

5301 Stevens Creek Boulevard, Santa Clara, CA 95051, US

القطاع

الرعاية الصحية

الصناعة

التشخيص والأبحاث الطبية

تاريخ الطرح العام الأولي

18 نوفمبر 1999

البورصة

NYSE

رمز ISIN

US00846U1016

الموقع الالكتروني:agilent.com

عن الشركة

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

عدد الموظفين

كان لدى شركة Agilent Technologies نحو 18,100 موظف في نهاية السنة المالية 2025 (31 أكتوبر 2025)، بحسب تقريرها السنوي. أي بزيادة 1.1% عن العام السابق.

عدد الموظفين في نهاية كل سنة مالية كما تذكره الشركة في تقريرها السنوي (⁦10-K⁩)؛ والإيرادات وصافي الدخل لكل موظف هي أرقام السنة المالية مقسومة على هذا العدد.

من يملك شركة Agilent Technologies

امتلكت المؤسسات مثل الصناديق والبنوك وشركات التأمين 93.3% من أسهم شركة Agilent Technologies في 30 يونيو 2026، وأفصحت 1,168 مؤسسة منها عن ملكيتها لهيئة الأوراق المالية الأمريكية؛ ويملك الباقي المستثمرون الأفراد ومساهمون آخرون.

أسئلة شائعة حول شركة Agilent Technologies